Lexicon Pharmaceuticals
LXRX
#6646
Rank
โ‚น77.99 B
Marketcap
โ‚น175.18
Share price
0.54%
Change (1 day)
26.94%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น13.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น13.12. In 2025 the company made an earnings per share (EPS) of -โ‚น13.12 an increase over its 2024 EPS that were of -โ‚น59.96.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น13.11-0.02%
2025-โ‚น13.12-78.13%
2024-โ‚น59.96-20%
2023-โ‚น74.9431.15%
2022-โ‚น57.14-0%
2021-โ‚น57.1410.91%
2020-โ‚น51.52-145.08%
2019โ‚น114.29-206.09%
2018-โ‚น107.73-5.74%
2017-โ‚น114.29-10.95%
2016-โ‚น128.342640%
2015-โ‚น4.68-96.34%
2014-โ‚น127.83-2.53%
2013-โ‚น131.15-9.09%
2012-โ‚น144.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,779-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น551.78-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,401-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น486.20 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น242.63-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.87-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น70.26 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.43-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,744 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA